Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Process & Production
Return to: PBR Home | Production & Manufacturing | Process & Production

Process & Production

Depomed announces settlements with two Gralise ANDA filers US-based specialty pharmaceutical company Depomed has announced it has entered into settlement agreements with two of the three defendants involved in the company's ongoing patent infringement litigation against filers of Abbreviated New Drug Applications (ANDAs) seeking approval to market generic versions of its Gralise (gabapentin) 300mg and 600mg tablets.
Production & Manufacturing > Process & Production > News
Advaxis announces notice of allowance for two patent applications in Japan Advaxis, a biotechnology company, has announced that the Japan Patent Office issued to the company two notices of allowance for two patent applications (P-72863-JP, P-7924) with claims for each patent application related to the company's proprietary cancer immunotherapy platform technology.
Production & Manufacturing > Process & Production > News Federal judge enforces settlement agreement between Mylan and Endo Pharmaceuticals regarding generic Frova Mylan has confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals and the company settling patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) for Frovatriptan Succinate Tablets, 2.5mg.
Production & Manufacturing > Process & Production > News
See more Process & Production news

Latest Process & Production News and Insight

View all Process & Production news or find news targeted to your interests
Fate gets US patent for class of small molecule modulators of Rho-associated kinase
By PBR Staff Writer
US-based biopharmaceutical firm Fate Therapeutics has announced that the US Patent and Trademark Office (PTO) has issued Patent No. 8,691,573 entitled 'Stem Cell Cultures.'
Production & Manufacturing > Process & Production > News
USPTO grants additional patent to BrainStorm for autologous stem cell technology
By PBR Staff Writer
The US Patent and Trademark Office (USPTO) has granted an additional patent to BrainStorm Cell Therapeutics, a developer of adult stem cell technologies for neurodegenerative diseases, for its autologous stem cell technology.
Production & Manufacturing > Process & Production > News
Fate Therapeutics gets US patent for class of small molecule modulators of Rho-associated kinase
Fate Therapeutics, a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, has announced today that the US Patent and Trademark Office (PTO) has issued Patent No. 8,691,573 entitled ‘Stem Cell Cultures’.
Production & Manufacturing > Process & Production > News
EMA announces final steps for its clinical-trial data policy
The European Medicines Agency (EMA) will launch a final round of targeted consultations with key stakeholders on its draft policy on proactive publication of and access to clinical-trial data at the beginning of May 2014.
Production & Manufacturing > Process & Production > News
Alnylam's McSwiggen patent upheld in European opposition proceedings
Alnylam Pharmaceuticals has announced that the European Patent Office (EPO) has upheld the McSwiggen EP 1423406 ('406) patent in oral opposition proceedings in Munich, Germany.
Production & Manufacturing > Process & Production > News
MEDELPHARM - Tabletting Technologies Made in France
Headquartered in Lyon, South-East France, Medelpharm is a manufacturer of specialised tablet presses. Our R&D services create innovative solutions for powder compaction simulation for the pharmaceutical, chemical and food industries.
Production & Manufacturing > Process & Production > Suppliers
JPMA's sanctions against Takeda for promotional activities of CASE-J
By PBR Staff Writer
Takeda Pharmaceutical (Takeda) has received notice of sanctions imposed by the Japan Pharmaceutical Manufacturers Association (JPMA) for promotional activities regarding Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J).
Production & Manufacturing > Process & Production > News
USPTO rejects Teva's '808 patent reissue application on Copaxone for second time
Mylan has announced that the US Patent and Trademark Office (USPTO) issued a final office action rejecting Teva's application seeking a reissue of US Patent No. 5,800,808 (the '808 Patent), which was found to be invalid by the Court of Appeals for the Federal Circuit in July 2013.
Production & Manufacturing > Process & Production > News
Mersana gets patent with broad coverage for Fleximer-ADC platform technology
Mersana Therapeutics, a US-based biopharmaceutical firm developing its Fleximer antibody-drug conjugate (ADC) platform and therapeutics, has announced that it was awarded US Patent No. 8,685,383, entitled 'Protein-Polymer-Drug Conjugates'.
Production & Manufacturing > Process & Production > News
VGTI Florida Scientists gets US patent for PD-1 Gene Expression Profiles
The Vaccine and Gene Institute of Florida (VGTI Florida) has announced that the US Patent and Trademark Office awarded VGTI Florida scientists Dr. Rafick-Pierre Sékaly, PhD and Dr. Elias Haddad, PhD U.S. Patent No. 8,647,822 titled DETERMINING WHETHER A TEST COMPOUND MODULATES PD-1 ACTIVITY IN ACTIVATED IMMUNE CELLS USING GENE EXPRESSION PROFILES.
Production & Manufacturing > Process & Production > News
View all Process & Production news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250